Anthem Biosciences Limited was originally incorporated as 'Anthem Biosciences Private Limited', dated June 13, 2006, issued by RoC. Subsequently, Company was converted from a Private Company to a Public Company , followed by the change in name of the Company to 'Anthem Biosciences Limited' and a Certificate of Incorporation was issued by RoC on December 10, 2024.
The Company has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries.
The Company started operations at Unit I and set up a Custom Synthesis Plant with a capacity of 6 KL in ... year 2007. It commenced discovery biology services with a fermentation capacity of 2 KL in 2008. It expanded the Custom Synthesis Plant at Unit I increasing its capacity from 6 KL to 24 KL in 2010. It set up a high potent lab at Unit I - Bommasandra Facility in 2016. The Company was merged with Anthem Cellutions (India) Private Limited by acquiring 100% of its share capital in November, 2017. It set up a flow chemistry lab scale and solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1. It commenced operations of the Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL in 2018-19. In year 2020, Company started operations to biological unit 2 earmarked for a specific client. It expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL. In FY 2024, Company set up a wholly owned subsidiary Neoanthem Lifesciences Private Limited and commenced operations at Unit III for development in projects.
Company launched the initial public offering of 59,575,319 equity shares of face value of Rs 2 each by raising funds through offer for sale aggregating to Rs 3395 Crore in July, 2025.
The Company expanded the fermentation capacity to 140 KL at the Unit II in 2025.
Similar Stocks
Company
52 Week
Market Price
P/E Ratio
FAQs on Anthem Biosciences Ltd
1. Can I buy Anthem Biosciences Ltd from PL Capital? ›
Yes, you can invest in Anthem Biosciences Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Anthem Biosciences Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Anthem Biosciences Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Anthem Biosciences Ltd pay dividends? ›
Anthem Biosciences Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Anthem Biosciences Ltd ? ›
As of
23-09-2025 the share price for Anthem Biosciences Ltd. is 821.85 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Anthem Biosciences Ltd ? ›
The 52-week high and low of Anthem Biosciences Ltd share price is ₹ 701.9 - ₹ 873.5 as of
23-09-2025 .
PL Ringside View
Our fireside chat series where industry experts and top management share valuable insights for our clients
